’s first original service 'limits dead ends and unexpected surprises'

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Pinkeypills)
(Image: Getty/Pinkeypills)

Related tags: Data,

The online marketplace for outsourced research launches its first original service, which will provide researchers with on-demand insights into clinical trials – including trends in what is ‘hot’ and what is ‘not,’ says CBO.

The new service, Trial Insights, is a digital reporting solution, which collates data every night from publicly-available data sources such as

“The Trial Insights reporting dashboard is intended for those on the edge of evaluating an acquisition, looking for investigators to run their trial, wanting to keep tabs on competitors, as well as looking for trends in what is ‘hot’ and what is ‘not’ in drugs, targets, and biomarkers,” ​said Mark Herbert, chief business officer (CBO),

“Trial Insights bridges the gap between integrated enterprise solutions, public databases, and mass export economy reports,”​ he told us.

Herbert said subscribers to the new service can scan for trends, avoid underperforming sites, identify new opportunities, access investigator heat maps, biomarker data, and more. This tailored data, delivered in real-time, can be shared to help users make better-informed decisions, he added.

“Trial Insights limits dead ends and unexpected surprises quickly and efficiently, so there are no wasted budgets,” ​Herbert said.

Related topics: Clinical Development, Data management

Related news

Show more

Related products

show more

Overcoming Challenges of Clinical Data Review

Overcoming Challenges of Clinical Data Review

PerkinElmer | 10-Jun-2021 | Technical / White Paper

Clinical data review is intrinsic to clinical development, assuring patient safety, determining drug efficacy, and assessing data quality. It involves...

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Related suppliers

Follow us


View more